Ministry of Education and Science of Ukraine Sumy State University 0
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Portal Vein Stenting for Jejunal Variceal Bleeding After Recurrence of Pancreatic Adenocarcinoma: a Case Report and Review of the Literature
Case Report Portal Vein Stenting for Jejunal Variceal Bleeding after Recurrence of Pancreatic Adenocarcinoma: A Case Report and Review of the Literature 1) Department of Radiology, Kyushu University Beppu Hospital, Japan 2) Department of Surgery, Kyushu University Beppu Hospital, Japan 3) Department of Clinical Radiology, Graduate School of Medical Science, Kyushu University, Japan Seiichiro Takao1), Masakazu Hirakawa1), Kazuki Takeishi2), Yushi Motomura1), Katsumi Sakamoto1), Hajime Otsu2), Yusuke Yonemura2), Koshi Mimori2), Kousei Ishigami3) Abstract A 73-year-old woman with portal vein stenosis caused by tumor recurrence after pancreatoduodenectomy was treated with stent placement without embolization of the jejunal varix. Anticoagulation therapy using heparin followed by rivaroxaban was administered after the procedure. She continued to receive systemic chemotherapy as an outpatient. Neither restenosis nor stent thrombosis was observed after 7 months. Based on the presented case and literature review, portal vein stenting is an effective treatment option for jejunal variceal bleeding caused by malignant portal venous stricture after pancreaticoduodenectomy. Antithrombotic therapy following portal venous stenting is required to prevent stent thrombosis in the majority of cases, al- though it has a risk of inducing recurrent variceal bleeding. Adjunctive jejunal variceal embolization can pos- sibly be omitted in selected cases to obtain sufficient portal-SMV flow reconstruction. Key words: Portal vein, Constriction, Stents (Interventional Radiology 2021; 6: 44-50) port describes a case of successful stenting for a patient Introduction with portal venous stenosis and bleeding from jejunal varices after pancreatoduodenectomy, along with the relevant Recurrent pancreatic cancer can cause portal venous literature. stenosis, resulting in symptoms of portal hypertension, such as hemorrhagic tendencies and liver dysfunction. -
Name: Ofoegbu, Ebubechukwu .C. Matric Number: 17/Mhs01/232 Course Code: Gross Anatomy of Head and Neck Department: Medicine and Surgery Level: 300
NAME: OFOEGBU, EBUBECHUKWU .C. MATRIC NUMBER: 17/MHS01/232 COURSE CODE: GROSS ANATOMY OF HEAD AND NECK DEPARTMENT: MEDICINE AND SURGERY LEVEL: 300 Question 1) Write an essay on the cavernous sinuses. The dural venous sinuses include the superior sagittal, inferior sagittal, straight, transverse, sigmoid, and occipital sinuses, the confluence of sinuses, and the cavernous, sphenoparietal, superior petrosal, inferior petrosal, and basilar sinuses. CAVERNOUS SINUSES Diagram of the cavernous sinus The cavernous sinus, a large venous plexus, is located on each side of the sella turcica on the upper surface of the body of the sphenoid, which contains the sphenoid (air) sinus. They are enclosed by the endosteal and meningeal layers of the dura mater. The borders of the cavernous sinus are: i) Superior Orbital fissure anteriorly. ii) The Petrous part of the temporal bone posteriorly. iii) The body of sphenoid medially. iv) The meningeal layer of the dura mater running from the roof of the middle cranial fossa, laterally. v) The roof is formed by the meningeal layer of the dura mater that attaches to the anterior and middle clinoid processes of the sphenoid bone. vi) The floor is formed by the endosteal layer of the dura mater that overlies the base of the greater wing of sphenoid bone. The cavernous sinuses receive blood not only from cerebral veins, but also from the ophthalmic veins (from the orbit) and emissary veins (from the pterygoid plexus of veins in the infratemporal fossa). These connections provide pathways for infections to pass from extracranial sites into intracranial locations. In addition, because structures pass through the cavernous sinuses and are located in the walls of these sinuses they are vulnerable to injury due to inflammation. -
Autologous Unilateral Breast Reconstruction with Venous Supercharged IMAP-Flaps: a Step by Step Guide of the Split Breast Technique
Journal of Clinical Medicine Article Autologous Unilateral Breast Reconstruction with Venous Supercharged IMAP-Flaps: A Step by Step Guide of the Split Breast Technique , Kathrin Bachleitner * y, Laurenz Weitgasser y, Amro Amr and Thomas Schoeller Department of Hand, Breast, and Reconstructive Microsurgery, Marienhospital Stuttgart, 70199 Stuttgart, Germany; [email protected] (L.W.); [email protected] (A.A.); [email protected] (T.S.) * Correspondence: [email protected]; Tel.: +49-711-6489-7202 Both authors contributed equally to this work. y Received: 13 August 2020; Accepted: 18 September 2020; Published: 20 September 2020 Abstract: Various techniques for breast reconstruction ranging from reconstruction with implants to free tissue transfer, with the disadvantage of either carrying a foreign body or dealing with donor site morbidity, have been described. In patients who had a unilateral mastectomy and offer a contralateral mamma hypertrophy a breast reconstruction can be performed with the excess tissue from the hypertrophic side using the split breast technique. Here a local internal mammary artery perforator (IMAP) flap of the hypertrophic breast can be used for reconstruction avoiding the downsides of implants or a microsurgical reconstruction and simultaneously reducing the enlarged donor breast in order to achieve symmetry. Methods: Between April 2010 and February 2019 the split breast technique was performed in five patients after mastectomy due to breast cancer. Operating time, length of stay, complications and the need for secondary operations were analyzed and the surgical technique including flap supercharging were described in detail. Results: All five IMAP-flaps survived and an aesthetically pleasant result could be achieved using the split breast technique. -
Anatomical Overview
IKOdontogenetic infection is spreaded Možné projevy zlomenin a zánětů IKPossible signs of fractures or inflammations Submandibular space lies between the bellies of the digastric muscles, mandible, mylohyoid muscle and hyoglossus and styloglossus muscles IK IK IK IK IK Submandibulární absces Submandibular abscess IK Sběhlý submandibulární absces Submandibular abscess is getting down IK Submental space lies between the mylohyoid muscles and the investing layer of deep cervical fascia superficially IK IK Spatium peritonsillare IK IK Absces v peritonsilární krajině Abscess in peritonsilar region IK Fasciae Neck fasciae cervicales Demarcate spaces • fasciae – Superficial (investing): • f. nuchae, f. pectoralis, f. deltoidea • invests m. sternocleidomastoideus + trapezius • f. supra/infrahyoidea – pretrachealis (middle neck f.) • form Δ, invests infrahyoid mm. • vagina carotica (carotic sheet) – Prevertebral (deep cervical f.) • Covers scaleni mm. IK• Alar fascia Fascie Fascia cervicalis superficialis cervicales Fascia cervicalis media Fascia cervicalis profunda prevertebralis IKsuperficialis pretrachealis Neck spaces - extent • paravisceral space – Continuation of parafaryngeal space – Nervous and vascular neck bundle • retrovisceral space – Between oesophagus and prevertebral f. – Previsceral space – mezi l. pretrachealis a orgány – v. thyroidea inf./plx. thyroideus impar • Suprasternal space – Between spf. F. and pretracheal one IK– arcus venosus juguli 1 – sp. suprasternale suprasternal Spatia colli 2 – sp. pretracheale pretracheal 3 – -
Human Anatomy As Related to Tumor Formation Book Four
SEER Program Self Instructional Manual for Cancer Registrars Human Anatomy as Related to Tumor Formation Book Four Second Edition U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutesof Health SEER PROGRAM SELF-INSTRUCTIONAL MANUAL FOR CANCER REGISTRARS Book 4 - Human Anatomy as Related to Tumor Formation Second Edition Prepared by: SEER Program Cancer Statistics Branch National Cancer Institute Editor in Chief: Evelyn M. Shambaugh, M.A., CTR Cancer Statistics Branch National Cancer Institute Assisted by Self-Instructional Manual Committee: Dr. Robert F. Ryan, Emeritus Professor of Surgery Tulane University School of Medicine New Orleans, Louisiana Mildred A. Weiss Los Angeles, California Mary A. Kruse Bethesda, Maryland Jean Cicero, ART, CTR Health Data Systems Professional Services Riverdale, Maryland Pat Kenny Medical Illustrator for Division of Research Services National Institutes of Health CONTENTS BOOK 4: HUMAN ANATOMY AS RELATED TO TUMOR FORMATION Page Section A--Objectives and Content of Book 4 ............................... 1 Section B--Terms Used to Indicate Body Location and Position .................. 5 Section C--The Integumentary System ..................................... 19 Section D--The Lymphatic System ....................................... 51 Section E--The Cardiovascular System ..................................... 97 Section F--The Respiratory System ....................................... 129 Section G--The Digestive System ......................................... 163 Section -
Guidance for the Format and Content of the Protocol of Non-Interventional
PASS information Title Metformin use in renal impairment Protocol version identifier Version 2 Date of last version of 30 October 2013 protocol EU PAS register number Study not registered Active substance A10BA02 metformin Medicinal product Metformin Product reference N/A Procedure number N/A Marketing authorisation 1A Farma, Actavis, Aurobindo, Biochemie, Bluefish, holder(s) Hexal, Mylan, Orifarm, Pfizer, Sandoz, Stada, Teva Joint PASS No Research question and To assess the use and safety of metformin in patients objectives with and without renal insufficiency in current clinical practice in at least two EU Member States. Country(-ies) of study Denmark, United Kingdom Author Christian Fynbo Christiansen, MD, PhD Page 1/214 Marketing authorisation holder(s) Marketing authorisation N/A holder(s) MAH contact person N/A Page 2/214 1. Table of Contents PASS information .......................................................................................................... 1 Marketing authorisation holder(s) .................................................................................... 2 1. Table of Contents ...................................................................................................... 3 2. List of abbreviations ................................................................................................... 4 3. Responsible parties .................................................................................................... 5 4. Abstract .................................................................................................................. -
II. DIGESTIV SYSTEM TESTS General Data 1. CS the Organ Represent: A
II. DIGESTIV SYSTEM TESTS General data 1. CS The organ represent: a) a structure made up by three layers b) a hollow element c) a part of the body built by complex of tissues integrated to realize the common functions d) a parenchymatous formation located in abdominal cavity e) a formation constituted by epithelium, vessels and nerves 2. CS The visceral apparatus is considered: a) The organs of different systems with diverse structure involved in performing some functions. b) the organs of neck region c) the organs located in the lesser pelvis d) the organs realized protective function e) the organs located at the border between thoracic and abdominal cavities 3. CS The primary gut is developed from: a) ectoderm b) mesoderm c) endoderm d) dermatome e) myotome 4. CS From which embryonic layer is developed the primary intestine : a) entoderm b) ectoderm c) sclerotome d) mesoderm e) splanhnopleura 5. CM The Viscera represents: a) the organs localized in abdominal cavity b) the systems of organs realized the connection of the body and external environment c) the organs and system of organs located in body’s cavities which realized the metabolic functions to sustain the life d) the complex of organs from abdominal and pelvic cavities e) the complex of organs from thoracic cavity 6. CM According by structure the organs are divided in: a) serous b) parenchymatous c) glandular d) epithelial e) hollow 7. CM Name two functions of the organic stroma: a) secretory b) trophic c) hematopoietic d) metabolic e) sustaining 8. CM The hollow organs distinguish the following layers: a) mucous b) submucous c) muscular d) membranous e) serous 9. -
Nasal Cavity •
DR MOUIN ABBOUD pr of anatomy Faculity of medicin Damascus and sham universiies جهاز التنفس The Respiratory System مقدمة: • إن جهاز التنفس هو المسئول عن وظيفة التبادل الدموي الغازي وإضافة لذلك تقوم بعض أجزائه العلوية بإنتاج الصوت وضبطه • يتألف جهاز التنفس من: • أ ـ طرق تنفسية علوية وسفلية : يتم عبرها نقل الهواء الحامل لﻷكسجين بعد تهيئته إلى منطقة التبادل الدموي الغازي . • ب ـ الرئتين والتي تحتوي كل منها نهاية الطرق الهوائية منطقة التبادل الدموي الغازي والتي يصل إليها نهاية الشرايين الرئوية الحاملة لغاز الفحم . • ج ـ أجزاء مساعدة وضابطة )غشاء الرئة – الجدار الصدري – الحجاب الحاجز-الجهاز العصبي (. الطرق التنفسية العلوية في العنق • وهي: اﻷنف ـ البعلوم اﻷنفي ـ الحنجرة - الرغامى • وتكون هذه الطرق مبطنة بغشاء مخاطي غني باﻷوعية الدموية من أجل ترطيب الهواء الداخل وتدفئته. The Respiratory System in the Head and Neck • The Respiratory System in the Head and Neck are : – The nose and paranasal sinuses – The pharynx – The larynx – The trachea Respiratory System Figure 22.1 اﻷنف The Nose: • هو الجزء المتواجد في الوجه • ويتم عبره نقل الهواء كما يحتوي أعضاء الشم THE NOSE • The nose is an olfactory and respiratory organ. • It consists of nasal skeleton, which houses the nasal cavity • . The nose can be divided into : – The external nose . – The nasal cavity, both of which are divided by a septum into right and left halves وظائف اﻷنف • .1 تدفئة Warming و ترطيب Humidifying الهواء المستنشق. • .2 عملية تنظيف و احتجاز الغبار و العوامل الممرضة • .3 عملية الشم Smell . • .4 تنفتح عليه الجيوب الهوائية جانب اﻷنفية لتصريف المخاط الذي تنتجه، باﻹضافة إلى • القناة الدمعية التي تصرف الدمع إلى المجرى اﻷنفي. -
ANATOMIC and PATHOLOGIC ASSESSMENT of FELINE LYMPH NODES USING COMPUTED TOMOGRAPHY and ULTRASONOGRAPHY Mauricio Tobón Restrepo
ADVERTIMENT. Lʼaccés als continguts dʼaquesta tesi queda condicionat a lʼacceptació de les condicions dʼús establertes per la següent llicència Creative Commons: http://cat.creativecommons.org/?page_id=184 ADVERTENCIA. El acceso a los contenidos de esta tesis queda condicionado a la aceptación de las condiciones de uso establecidas por la siguiente licencia Creative Commons: http://es.creativecommons.org/blog/licencias/ WARNING. The access to the contents of this doctoral thesis it is limited to the acceptance of the use conditions set by the following Creative Commons license: https://creativecommons.org/licenses/?lang=en Doctorand: Mauricio Tobón Restrepo Directores: Yvonne Espada Gerlach & Rosa Novellas Torroja Tesi Doctoral Barcelona, 29 de juliol de 2016 This thesis has received financial support from the Colombian government through the “Francisco José de Caldas” scholarship program of COLCIENCIAS and from the Corporación Universitaria Lasallista. DEDICATED TO A los que son la razón y la misión de esta tesis… LOS GATOS. A mis padres y hermanos. A Ismael. Vor mijn poffertje. ACKNOWLEDGMENTS Tal vez es la parte que se pensaría más fácil de escribir, pero sin duda se juntan muchos sentimientos al momento de mirar atrás y ver todo lo que has aprendido y todas las personas que han estado a tu lado dándote una palabra de aliento… y es ahí cuando se asoma la lágrima… Sin duda alguna, comienzo agradeciendo a los propietarios de todos los gatos incluidos en este estudio, sin ellos esto no habría sido posible. A continuación agradezco a mis directoras de tesis, la Dra. Rosa Novellas y la Dra. Yvonne Espada. Muchas gracias por creer en mí, por apoyarme y por tenerme tanta paciencia. -
M. H. RATZLAFF: the Superficial Lymphatic System of the Cat 151
M. H. RATZLAFF: The Superficial Lymphatic System of the Cat 151 Summary Four examples of severe chylous lymph effusions into serous cavities are reported. In each case there was an associated lymphocytopenia. This resembled and confirmed the findings noted in experimental lymph drainage from cannulated thoracic ducts in which the subject invariably devdops lymphocytopenia as the lymph is permitted to drain. Each of these patients had com munications between the lymph structures and the serous cavities. In two instances actual leakage of the lymphography contrrult material was demonstrated. The performance of repeated thoracenteses and paracenteses in the presenc~ of communications between the lymph structures and serous cavities added to the effect of converting the. situation to one similar to thoracic duct drainage .The progressive immaturity of the lymphocytes which was noted in two patients lead to the problem of differentiating them from malignant cells. The explanation lay in the known progressive immaturity of lymphocytes which appear when lymph drainage persists. Thankful acknowledgement is made for permission to study patients from the services of Drs. H. J. Carroll, ]. Croco, and H. Sporn. The graphs were prepared in the Department of Medical Illustration and Photography, Dowristate Medical Center, Mr. Saturnino Viloapaz, illustrator. References I Beebe, D. S., C. A. Hubay, L. Persky: Thoracic duct 4 Iverson, ]. G.: Phytohemagglutinin rcspon•e of re urctcral shunt: A method for dccrcasingi circulating circulating and nonrecirculating rat lymphocytes. Exp. lymphocytes. Surg. Forum 18 (1967), 541-543 Cell Res. 56 (1969), 219-223 2 Gesner, B. M., J. L. Gowans: The output of lympho 5 Tilney, N. -
MSS 1. a Patient Presented to a Traumatologist with a Trauma Of
MSS 1. A patient presented to a traumatologist with a trauma of shoulder. What wall of axillary cavity contains foramen trilaterum and foramen quadrilaterum? a) anterior b) posterior c) lateral d) medial e) intermediate 2. A patient presented to a traumatologist with a trauma of leg, which he had sustained at a sport competition. Upon examination, damage of posterior muscle, that is attached to calcaneus by its tendon, was found. This muscle is: a) triceps surae b) tibialis posterior c) popliteus d) fibularis longus e) fibularis brevis 3. In the course of a cesarean section, an incision was made in the pubic area and vagina of rectus abdominis muscle was cut. What does anterior wall of the vagina of rectus abdominis muscle consist of? A. aponeurosis of m. transversus abdominis, m. obliquus internus abdominis. B. aponeurosis of m. transversus abdominis, m. pyramidalis. C. aponeurosis of m. obliquus internus abdominis, m. obliquus externus abdominis. D. aponeurosis of m. transversus abdominis, m. obliquus externus abdominis. E. aponeurosis of m. transversus abdominis, m. obliquus internus abdominis 4. A 30 year-old woman complained of pain in the lower part of her forearm. Traumatologist found that her radio-carpal joint was damaged. This joint is: A. complex, ellipsoid B.simple, ellipsoid C.complex, cylindrical D.simple, cylindrical E.complex condylar 5. A woman was brought by an ambulance to the emergency department with a trauma of the cervical part of her vertebral column. Radiologist diagnosed a fracture of a nonbifid spinous processes of one of her cervical vertebrae. Spinous process of what cervical vertebra is fractured? A.VI. -
Collaborative Stage Manual Part II
SEER Program Coding and Staging Manual 2004, Revision 1 Collaborative Staging Codes Nasal Cavity C30.0 C30.0 Nasal cavity (excludes nose, NOS C76.0) Note: Laterality must be coded for this site, except subsites Nasal cartilage and Nasal septum, for which laterality is coded 0. CS Tumor Size CS Site-Specific Factor 1 - Size of The following tables are available CS Extension Lymph Nodes at the collaborative staging CS TS/Ext-Eval CS Site-Specific Factor 2 - website: CS Lymph Nodes Extracapsular Extension, Lymph Nodes Histology Exclusion Table CS Reg Nodes Eval for Head and Neck AJCC Stage Reg LN Pos CS Site-Specific Factor 3 - Levels I- Lymph Nodes Size Table Reg LN Exam III, Lymph Nodes for Head and Neck CS Mets at DX CS Site-Specific Factor 4 - Levels IV- CS Mets Eval V and Retropharyngeal Lymph Nodes for Head and Neck CS Site-Specific Factor 5 - Levels VI- VII and Facial Lymph Nodes for Head and Neck CS Site-Specific Factor 6 - Parapharyngeal, Parotid, Preauricular, and Sub-Occipital Lymph Nodes, Lymph Nodes for Head and Neck Nasal Cavity CS Tumor Size SEE STANDARD TABLE Nasal Cavity CS Extension Code Description TNM SS77 SS2000 00 In situ; non-invasive Tis IS IS 10 Invasive tumor confined to site of origin T1 L L Meatus (superior, middle, inferior) Nasal chonchae (superior, middle, inferior) Septum Tympanic membrane 30 Localized, NOS T1 L L 40 Extending to adjacent connective tissue within the nasoethomoidal T2 RE RE complex Nasolacrimal duct 60 Adjacent organs/structures including: T3 RE RE Bone of skull Choana Frontal sinus Hard palate